Companies / LeMaitre Vascular, Inc. / Activity
Activity — LeMaitre Vascular, Inc.
180 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | George W. LeMaitre CEO | Sell | Common Stock | $16.01M | -150K -8.92% | 1,532,304 6.70% of shares | high |
| Mar 2, 2026 | George W. LeMaitre CEO | Sell | Common Stock | $6.03M | -56K -3.65% | 1,476,500 6.46% of shares | medium |
| May 8, 2026 | George W. LeMaitre CEO | Sell | Common Stock | $3.03M | -28K -1.91% | 1,430,019 6.25% of shares | medium |
| May 7, 2026 | George W. LeMaitre CEO | Sell | Common Stock | $2.00M | -19K -1.26% | 1,457,900 6.37% of shares | medium |
| Feb 27, 2026 | Roberts David B Executive | Sell | Common Stock | $904.0K | -8K -32.01% | 17,979 0.08% of shares | medium |
| May 7, 2026 | Ross Bridget A Director | Sell | Common Stock | $560.4K | -5K -56.13% | 3,942 0.02% of shares | medium |
| May 7, 2026 | Jasinski Lawrence J Director | Sell | Common Stock | $433.7K | -4K -45.55% | 4,714 0.02% of shares | medium |
| Mar 11, 2026 | Roberts David B Executive | Sell | Common Stock | $356.6K | -3K -18.42% | 14,667 0.06% of shares | medium |
| May 8, 2026 | Kamke Trent G Executive | Sell | Common Stock | $313.3K | -3K -43.85% | 3,749 0.02% of shares | medium |
| Mar 11, 2026 | Kamke Trent G Executive | Sell | Common Stock | $284.8K | -3K -28.22% | 6,677 0.03% of shares | medium |
| May 7, 2026 | Ross Bridget A Director | Exercise | Common Stock | $167.4K | +3K +87.37% | 7,386 0.03% of shares | low |
| Feb 27, 2026 | Kamke Trent G Executive | Sell | Common Stock | $115.1K | -1K -13.52% | 6,677 0.03% of shares | medium |
| Apr 22, 2026 | Pellegrino Joseph P JR Director | Exercise | Common Stock | $104.3K | +3K +24.35% | 15,021 0.07% of shares | low |
| Feb 5, 2026 | Roberts David B Executive | Exercise | Common Stock | $99.6K | +3K +12.01% | 24,923 0.11% of shares | low |
| Mar 11, 2026 | Kamke Trent G Executive | Exercise | Common Stock | $93.1K | +3K +39.31% | 9,302 0.04% of shares | low |
| May 7, 2026 | Jasinski Lawrence J Director | Exercise | Common Stock | $87.5K | +865 +11.10% | 8,657 0.04% of shares | low |
| May 7, 2026 | Ross Bridget A Director | Exercise | Common Stock | $75.5K | +2K +21.66% | 8,986 0.04% of shares | low |
| Feb 26, 2026 | George W. LeMaitre CEO | Other | Common Stock | $56.4K | -496 -0.03% | 1,537,430 6.72% of shares | low |
| Jan 8, 2026 | Kamke Trent G Executive | Exercise | Common Stock | $54.2K | +1K +19.75% | 6,761 0.03% of shares | low |
| May 7, 2026 | Jasinski Lawrence J Director | Exercise | Common Stock | $50.5K | +924 +13.45% | 7,792 0.03% of shares | low |
| May 7, 2026 | Jasinski Lawrence J Director | Exercise | Common Stock | $50.4K | +1K +18.43% | 6,868 0.03% of shares | low |
| Jan 8, 2026 | Kamke Trent G Executive | Exercise | Common Stock | $45.8K | +1K +27.82% | 5,646 0.02% of shares | low |
| Feb 26, 2026 | Roberts David B Executive | Other | Common Stock | $15.2K | -134 -0.50% | 26,456 0.12% of shares | low |
| Feb 26, 2026 | Kamke Trent G Executive | Other | Common Stock | $10.6K | -93 -1.19% | 7,721 0.03% of shares | low |
| Mar 10, 2026 | LeBlanc Dorian Paul Executive | Other | Common Stock | $10.5K | -96 -4.00% | 2,302 0.01% of shares | low |
| Feb 26, 2026 | Roberts David B Executive | Other | Common Stock | $1.5K | -13 -0.05% | 26,443 0.12% of shares | low |
| Feb 5, 2026 | Roberts David B Executive | Exercise | Common Stock | $340 | +7 +0.03% | 24,930 0.11% of shares | low |
| Jun 4, 2026 | George W. LeMaitre CEO | Grant | Common Stock | $0 | +12K +35.85% | 45,374 0.20% of shares | low |
| Jun 4, 2026 | George W. LeMaitre CEO | Gift | Common Stock | $0 | -12K -0.84% | 1,418,045 6.20% of shares | low |
| Feb 26, 2026 | Ross Bridget A Director | Exercise | Common Stock | $0 | +1 +0.03% | 3,942 0.02% of shares | low |
| Feb 26, 2026 | Ross Bridget A Director | Grant | Common Stock | $0 | +476 +13.74% | 3,941 0.02% of shares | low |
| Feb 26, 2026 | O'Connor John James Director | Exercise | Common Stock | $0 | +1 +<0.01% | 62,827 0.27% of shares | low |
| Feb 26, 2026 | O'Connor John James Director | Grant | Common Stock | $0 | +476 +0.76% | 62,826 0.27% of shares | low |
| Feb 26, 2026 | Jasinski Lawrence J Director | Exercise | Common Stock | $0 | +1 +0.02% | 5,799 0.03% of shares | low |
| Feb 26, 2026 | Jasinski Lawrence J Director | Grant | Common Stock | $0 | +476 +8.94% | 5,798 0.03% of shares | low |
| Feb 26, 2026 | Kamke Trent G Executive | Exercise | Common Stock | $0 | +2 +0.03% | 7,814 0.03% of shares | low |
| Feb 26, 2026 | Kamke Trent G Executive | Grant | Common Stock | $0 | +1K +15.54% | 7,812 0.03% of shares | low |
| Mar 2, 2026 | George W. LeMaitre CEO | Gift | Common Stock | $0 | -5K -0.33% | 1,532,430 6.70% of shares | low |
| Feb 26, 2026 | George W. LeMaitre CEO | Exercise | Common Stock | $0 | +13 +<0.01% | 1,537,926 6.72% of shares | low |
| Feb 26, 2026 | George W. LeMaitre CEO | Grant | Common Stock | $0 | +6K +0.37% | 1,537,913 6.72% of shares | low |
| Feb 26, 2026 | Pellegrino Joseph P JR Director | Exercise | Common Stock | $0 | +4 +0.03% | 12,080 0.05% of shares | low |
| Feb 26, 2026 | Pellegrino Joseph P JR Director | Grant | Common Stock | $0 | +2K +18.59% | 12,076 0.05% of shares | low |
| Feb 26, 2026 | Roberts David B Executive | Exercise | Common Stock | $0 | +3 +0.01% | 26,593 0.12% of shares | low |
| Feb 26, 2026 | Roberts David B Executive | Grant | Common Stock | $0 | +146 +0.55% | 26,590 0.12% of shares | low |
| Feb 26, 2026 | Roberts David B Executive | Grant | Common Stock | $0 | +2K +6.07% | 26,444 0.12% of shares | low |
| Feb 26, 2026 | Roush John A Director | Exercise | Common Stock | $0 | +1 +0.03% | 3,942 0.02% of shares | low |
| Feb 26, 2026 | Roush John A Director | Grant | Common Stock | $0 | +476 +13.74% | 3,941 0.02% of shares | low |
| Mar 10, 2026 | LeBlanc Dorian Paul Executive | Exercise | Common Stock | $0 | +2 +0.08% | 2,400 0.01% of shares | low |
| Feb 26, 2026 | Shadan Martha Director | Exercise | Common Stock | $0 | +1 +0.03% | 2,962 0.01% of shares | low |
| Feb 26, 2026 | Shadan Martha Director | Grant | Common Stock | $0 | +476 +19.15% | 2,961 0.01% of shares | low |